<TABLE> <S> <C>
<S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-Q
FOR THE PERIOD ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 877
<SECURITIES> 0
<RECEIVABLES> 1,546 <F1>
<ALLOWANCES> 0
<INVENTORY> 504
<CURRENT-ASSETS> 3,466
<PP&E> 1,939 <F1>
<DEPRECIATION> 0
<TOTAL-ASSETS> 8,675
<CURRENT-LIABILITIES> 8,636
<BONDS> 0
0
12,196
<COMMON> 140
<OTHER-SE> (100)
<TOTAL-LIABILITY-AND-EQUITY> 8,675
<SALES> 7,003
<TOTAL-REVENUES> 14,620
<CGS> 5,067
<TOTAL-COSTS> 10,241
<OTHER-EXPENSES> 3,394 <F2>
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 454
<INCOME-PRETAX> (9,996)
<INCOME-TAX> 15
<INCOME-CONTINUING> (10,010)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (10,010)
<EPS-BASIC> (1.10) <F3>
<EPS-DILUTED> (1.10)
<FN>
<F1> Item shown net of allowance, consistent with the balance sheet
presentation.
<F2> Item consists of research and development.
<F3> Item consists of basic earnings per share.
</FN>
</TABLE>
